SION – sionna therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says [Yahoo! Finance]
Sionna Therapeutics (NASDAQ:SION) had its "underperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $24.00 price target on the stock.
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
Sionna Therapeutics (NASDAQ:SION) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
Form 4 Sionna Therapeutics, For: Nov 24 Filed by: ORBIMED ADVISORS LLC
Form 4 Sionna Therapeutics, For: Nov 24 Filed by: Thompson Peter A.
Form 144 Sionna Therapeutics, Filed by: ORBIMED ADVISORS LLC
Form 4 Sionna Therapeutics, For: Nov 20 Filed by: RA Capital Nexus Fund, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.